4//SEC Filing
Davis Robert E 4
Accession 0001209191-19-001584
CIK 0001567514other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:42 PM ET
Size
15.2 KB
Accession
0001209191-19-001584
Insider Transaction Report
Form 4
Davis Robert E
SVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-01-03−16,160→ 32,320 total→ Common Stock (16,160 underlying) - Exercise/Conversion
Common Stock
2019-01-03+2,649→ 37,393 total - Exercise/Conversion
Common Stock
2019-01-03+16,160→ 53,553 total - Sale
Common Stock
2019-01-02$11.11/sh−4,834$53,706→ 34,744 total - Award
Common Stock
2018-12-31+9,322→ 39,578 total - Exercise/Conversion
Restricted Stock Units
2019-01-03−2,649→ 2,649 total→ Common Stock (2,649 underlying)
Footnotes (7)
- [F1]Represents shares issued upon the vesting of performance stock units.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2018. The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the vesting of performance stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.74 to $11.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]Restricted stock units convert into common stock on a one-for-one basis.
- [F5]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F6]On January 3, 2017, the reporting person was granted 7,946 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
- [F7]On January 3, 2018, the reporting person was granted 48,480 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001291959
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:42 PM ET
- Size
- 15.2 KB